Search results for "cognitive decline"

showing 10 items of 171 documents

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

2016

Background: The treatment and diagnosis of Alzheimer’s Disease (AD) are two of the most urgent goals for research around the world. The cognitive decline is generally associated with the elevated levels of extracellular senile plaques, intracellular neurofibril- lary tangles (NFTs), and with a progressive shutdown of the cholinergic basal forebrain neurons transmission. Even if several key targets are under fervent investigation in the cure of AD, till now, the only approved therapeutic strategy is the treatment of symptoms by using cholinesterases inhibitors. It has been demonstrated that both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes are not only responsible of…

Pathologymedicine.medical_specialtyTau proteinDisease010402 general chemistry01 natural scienceschemistry.chemical_compoundAlzheimer DiseaseHeterocyclic CompoundsDrug DiscoverymedicineAnimalsHumansSenile plaquesCognitive declineButyrylcholinesterasePharmacologybiologyMolecular Structure010405 organic chemistryChemistryAcetylcholinesterase0104 chemical sciencesbiology.proteinCholinergicNeuroscienceAmyloid precursor protein secretaseAlzheimer’s disease amyloid-peptide secretase acetylcholinesterase tau protein heterocycles
researchProduct

Oropharyngeal dysphagia in elderly population suffering from mild cognitive impairment and mild dementia: Understanding the link

2020

Abstract Purpose To evaluate the prevalence of oropharyngeal dysphagia in elderly patients suffering from minimal or mild cognitive decline. Patients and methods We retrospectively collected the data of patients suffering from mild cognitive impairment or mild dementia and were undergoing management for suspected oropharyngeal dysphagia, in our department. All our patients were subjected to Mini Mental State Examination test, MD Anderson dysphagia inventory and caregiver mealtime and dysphagia questionnaire. We performed a mealtime observation study and endoscopic evaluation of swallowing in all our patients. Following evaluation, we then analysed the data statistically. Results Out of 708 …

Pediatricsmedicine.medical_specialtyFEESComorbidity03 medical and health sciences0302 clinical medicineSwallowingAlzheimer Diseaseotorhinolaryngologic diseasesmedicineHumansCognitive DysfunctionCognitive decline030223 otorhinolaryngologyCognitive impairmentMD Anderson Dysphagia InventoryAgedRetrospective StudiesAged 80 and overMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryDysphagiaSwallowingAlzheimer'sDysphagiaDeglutitionCognitive impairmentOtorhinolaryngology030220 oncology & carcinogenesisMild dementiaDementiamedicine.symptomDeglutition DisordersbusinessOropharyngeal dysphagiaAmerican Journal of Otolaryngology
researchProduct

The cognitive profile of prion disease: a prospective clinical and imaging study

2015

Objectives Prion diseases are dementing illnesses with poorly defined neuropsychological features. This is probably because the most common form, sporadic Creutzfeldt-Jakob disease, is often rapidly progressive with pervasive cognitive decline making detailed neuropsychological investigation difficult. This study, which includes patients with inherited, acquired (iatrogenic and variant) and sporadic forms of the disease, is the only large-scale neuropsychological investigation of this patient group ever undertaken and aimed to define a neuropsychological profile of human prion diseases. Methods A tailored short cognitive examination of all of the patients (n = 81), with detailed neuropsycho…

Pediatricsmedicine.medical_specialtySettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryGeneral NeuroscienceNeuropsychologyCognitionDiseasePrion diseases cognitive declineBioinformaticsPRNPClinical trialBasal gangliamedicineNeurology (clinical)Differential diagnosisCognitive declinebusinessResearch ArticlesAnnals of Clinical and Translational Neurology
researchProduct

Faut-il réaliser un « Mini-Mental State Examination » chez tout sujet âgé hypertendu ?

2009

Hypertension constitutes a recognized risk factor of vascular dementia but also of Alzheimer-type dementia. Various longitudinal studies showed that midlife blood pressure level is one of the factors conditioning the onset of dementia syndrome in late life. The high risk of dementia is linked to leukoaraiosis, vascular rigidity, microcirculation disorders, oxidative stress, blood pressure fluctuations including orthostatic hypotension and strokes, all of those being associated with hypertension. Numerous clinical trials showed the positive effect of effective treatment of hypertension on the prevention of cognitive disorders and dementias. Thus, screening and early management of dementia an…

Pediatricsmedicine.medical_specialtybusiness.industryLeukoaraiosisCognitionmedicine.diseaseOrthostatic vital signsBlood pressuremental disordersmedicineDementiaRisk factorCognitive declineCardiology and Cardiovascular MedicineVascular dementiabusinessJournal des Maladies Vasculaires
researchProduct

Mental health perspectives of Hunter syndrome: Case reports of two biological siblings

2016

Hunter syndrome is a rare X-linked recessive disorder caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to progressive accumulation of a substance called glycosaminoglycans in nearly all cell types, tissues, and organs. Hunter syndrome presents with facial dysmorphism, airway diseases, skeletal defects, cardiomyopathies, and neuropsychiatric manifestations. Mental subnormality is a cardinal feature in Hunter syndrome. This is a progressive cognitive decline that is not amenable to enzyme replacement therapy. Due to progressive cognitive decline, training the children to improve the adaptive functioning is a challenge that creates immense stress for the caregivers.…

Pediatricsmedicine.medical_specialtybusiness.industrylcsh:Reducationlcsh:MedicineHunter syndromeGeneral MedicineEnzyme replacement therapycognitive declinemedicine.diseaseMental healthProgressive cognitive declineBiological siblingsAdaptive functioningFacial dysmorphismHunter syndromeMedicineCognitive declinebusinessMental subnormalityMedical Journal of Dr. D.Y. Patil University
researchProduct

Moderate alcohol use and health: a consensus document

2013

Abstract Aims The aim of this consensus paper is to review the available evidence on the association between moderate alcohol use, health and disease and to provide a working document to the scientific and health professional communities. Data synthesis In healthy adults and in the elderly, spontaneous consumption of alcoholic beverages within 30 g ethanol/d for men and 15 g/d for women is to be considered acceptable and do not deserve intervention by the primary care physician or the health professional in charge. Patients with increased risk for specific diseases, for example, women with familiar history of breast cancer, or subjects with familiar history of early cardiovascular disease, …

Polyphenolmedicine.medical_specialtyEndocrinology Diabetes and MetabolismMEDLINEMedicine (miscellaneous)Cognitive declineDiseaseDiabetealcohol; cancer; cardiovascular disease; cognitive decline; diabetes; metabolic syndrome; overall mortality; polyphenols; preventionALCOHOLIC LIVER DISEASEBreast cancerDiabetes mellitusIntervention (counseling)medicineOverall mortalityCognitive declinePsychiatrypolyphenolsCancerNutrition and Dieteticsdiabetesbusiness.industryPreventionPrimary care physicianmedicine.diseaseModerationCardiovascular diseaseMetabolic syndromeSettore MED/11 - Malattie Dell'Apparato CardiovascolareHEALTHCardiology and Cardiovascular MedicinebusinessAlcohol; Cardiovascular disease; Cancer; Prevention; Polyphenols; Diabetes; Metabolic syndrome; Cognitive decline; Overall mortalityAlcohol
researchProduct

Cognitive impairment and stroke in elderly patients.

2016

Daniele Lo Coco,1 Gianluca Lopez,1 Salvatore Corrao,2,31Neurology and Stroke Unit, 2Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, 3Centre of Research for Effectiveness and Appropriateness in Medicine (C.R.E.A.M.), Di.Bi.M.I.S., University of Palermo, Palermo, Italy Abstract: We reviewed current knowledge about the interaction between stroke and vascular risk factors and the development of cognitive impairment and dementia. Stroke is increasingly recognized as an important cause of cognitive problems and has been implicated in the development of both Alzheimer's disease and vascular dementia. Th…

Preventive Health ServiceGerontologylcsh:Diseases of the circulatory (Cardiovascular) systemAgingEndocrinology Diabetes and MetabolismDiseaseReview0302 clinical medicineCognitionRisk FactorsPreventive Health ServicesPrevalenceMedicineAge FactorPharmacology (medical)030212 general & internal medicineCognitive declineStrokeAged 80 and overAge FactorsCognitionHematologyGeneral MedicinePrognosiscerebrovascular diseaseStrokeCardiology and Cardiovascular MedicineRisk assessmentHumanPrognosielderlyRisk AssessmentVascular risk factorAging; Cerebrovascular disease; Cognitive function; Dementia; Vascular risk factors; Age Factors; Aged; Aged 80 and over; Aging; Cognition Disorders; Geriatric Assessment; Humans; Prevalence; Preventive Health Services; Prognosis; Quality of Life; Risk Assessment; Risk Factors; Stroke; Cognition; Cardiology and Cardiovascular Medicine; Pharmacology (medical); Public Health Environmental and Occupational Health; Hematology; Endocrinology Diabetes and MetabolismCognition Disorder03 medical and health sciencesDementiaHumansCognitive rehabilitation therapyVascular dementiaGeriatric Assessmentcognitive functioncognitive impairmentAgedbusiness.industryRisk FactorPublic Health Environmental and Occupational Healthmedicine.diseaselcsh:RC666-701vascular risk factorsQuality of LifebusinessCognition Disorders030217 neurology & neurosurgerydementiaVascular health and risk management
researchProduct

Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders

2011

In recent years, there has been a growing interest, supported by a large number of experimental and epidemi-ological studies, for the beneficial effects of some phenolic substances, contained in commonly used spices and herbs, in preventing various age-related pathologic conditions, ranging from cancer to neurodegenerative diseases. Although the exact mechanisms by which polyphenols promote these effects remain to be elucidated, several reports have shown their ability to stimulate a general xenobiotic response in the target cells, activating multiple defense genes. Data from our and other laboratories have previously demonstrated that curcumin, the yellow pigment of curry, strongly induces…

Programmed cell deathAntioxidantCurcuminNF-E2-Related Factor 2medicine.medical_treatmentCentral nervous systemNeuroscience (miscellaneous)InflammationPharmacologyBiologyResponse ElementsHeterodimers of NF-E2-related factors 2(Nrf2) Antioxidant responsive element (ARE) Heme oxygenase 1 (HO-1) Neurodegenerative disorders Alzheimer’s disease Polyphenols Curcumin (-)- epigallocatechin-3- gallate (EGCG) Brain ageingNeuroprotectionAntioxidantsCatechinArticleCellular and Molecular Neurosciencechemistry.chemical_compoundmedicineAnimalsHumansCognitive declineCaffeic acid phenethyl esterSettore MED/04 - Patologia GeneraleMolecular StructurePolyphenolsNeurodegenerative DiseasesDietmedicine.anatomical_structureNeuroprotective AgentsNeurologyBiochemistrychemistryFoodCurcuminmedicine.symptomCognition DisordersHeme Oxygenase-1
researchProduct

Influence of Severe Carotid Stenosis on Cognition, Depressive Symptoms and Quality of Life.

2017

Background: Carotid artery disease is not just a causal risk factor of ischemic stroke, but may predispose patients to depressive symptoms and low health related quality of life (HRQoL). Objectives: The objectives of the present study were to assess the association between severe carotid artery stenosis (CAS) and cognitive impairment, frequency of depressive symptoms and status of HRQoL. Methods: Cross - sectional study involved 55 patients with severe CAS and 54 patients with lower extremity peripheral artery disease (PAD). Cognitive impairment was assessed using Montreal Cognitive Assessment Scale (MoCA), depressive symptoms - PHQ-9 scale. HRQoL was measured using Medical Outcome Survey …

Quality of lifemedicine.medical_specialtyEpidemiologyDisease030204 cardiovascular system & hematologyLow healthArticle03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineCarotid artery diseaseCarotid stenosisMedicineCognitive declineRisk factorIschemic strokebusiness.industryDepressive symptomsMontreal Cognitive AssessmentCognitionmedicine.diseasehumanitiesPsychiatry and Mental healthStenosisCognitive impairmentPhysical therapybusiness030217 neurology & neurosurgeryClinical practice and epidemiology in mental health : CPEMH
researchProduct

The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort

2004

BACKGROUND: Knowledge of the evolution of cognitive deficits in Alzheimer disease is important for our understanding of disease progression. Previous reports, however, have either lacked detail or have not covered the presymptomatic stages. OBJECTIVE: To delineate the onset and progression of clinical and neuropsychological abnormalities in familial Alzheimer disease. METHODS: Nineteen subjects with familial Alzheimer disease underwent serial clinical and neuropsychological assessments. Eight of these had undergone presymptomatic assessments. The follow-up period was 1 to 10 years (mean, 5 years). The relative timing of the occurrence of 3 markers of disease onset and progression (onset of …

RISKSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCOGNITIVE DECLINEPRESENILIN-1 MUTATIONDIAGNOSIS
researchProduct